HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of primary aldosteronism: its complications and their outcomes after treatment.

Abstract
Primary aldosteronism is the most common cause of secondary hypertension, accounting for about 10% of all forms of high blood pressure. Life-time pharmacological therapy is the treatment of choice for primary aldosteronism due to idiopathic adrenal hyperplasia (IHA), while adrenalectomy is effective in curing most patients with an aldosterone producing adenoma (APA). Far from being a benign form of hypertension, primary aldosteronism is characterized by the development of cardiovascular renal and metabolic complications, including left ventricular hypertrophy, myocardial infarction, atrial fibrillation and stroke, microalbuminuria, renal cysts as well as metabolic syndrome, glucose impairment and diabetes mellitus. We review recent clinical experience with the above mentioned complications and long-term outcomes of blood pressure normalization and cardiac, renal and gluco-metabolic complications in patients with primary aldosteronism, after medical treatment with mineralocorticoid receptor antagonists and surgical treatment. We conclude that removal of adrenal adenoma results in normalization of the renin-angiotensin-aldosterone system (RAAS) and of kalaemia and improvement of blood pressure levels in all patients. Complete resolution of hypertension is achieved in nearly half of treated patients. Moreover, unilateral adrenalectomy is the best treatment to have the regression of cardiovascular, renal and metabolic complications in patients with APA. On the other hand, targeted medical treatment with aldosterone antagonists improves blood pressure control and appears able to prevent the progression of cardiac and metabolic complications in patients with IHA.
AuthorsGilberta Giacchetti, Federica Turchi, Marco Boscaro, Vanessa Ronconi
JournalCurrent vascular pharmacology (Curr Vasc Pharmacol) Vol. 7 Issue 2 Pg. 244-49 (Apr 2009) ISSN: 1570-1611 [Print] United Arab Emirates
PMID19356005 (Publication Type: Journal Article, Review)
Topics
  • Adenoma (complications, surgery)
  • Adrenal Gland Neoplasms (complications, surgery)
  • Adrenal Glands (pathology)
  • Adrenalectomy
  • Blood Pressure
  • Humans
  • Hyperaldosteronism (complications, etiology, therapy)
  • Hyperplasia
  • Hypertension (etiology, prevention & control)
  • Renin-Angiotensin System

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: